87 related articles for article (PubMed ID: 2642031)
1. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
Lindner W; Rath M; Stoschitzky K; Semmelrock HJ
Chirality; 1989; 1(1):10-3. PubMed ID: 2642031
[TBL] [Abstract][Full Text] [Related]
2. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
Paradiso-Hardy FL; Walker SE; Bowles SK
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
[TBL] [Abstract][Full Text] [Related]
4. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
[TBL] [Abstract][Full Text] [Related]
7. Age and gender influence the stereoselective pharmacokinetics of propranolol.
Gilmore DA; Gal J; Gerber JG; Nies AS
J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
[TBL] [Abstract][Full Text] [Related]
8. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
9. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
Stoschitzky K; Lindner W; Egginger G; Brunner F; Obermayer-Pietsch B; Passath A; Klein W
Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
Walle T; Walle UK
Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat.
Jamali F; Lovlin R; Corrigan BW; Davies NM; Aberg G
Chirality; 1999; 11(3):201-5. PubMed ID: 10079499
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits.
Hawkins MG; Taylor IT; Craigmill AL; Tell LA
J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of clinafloxacin enantiomers in humans.
Humphrey GH; Shapiro MA; Randinitis EJ; Guttendorf RJ; Brodfuehrer JI
J Clin Pharmacol; 1999 Nov; 39(11):1143-50. PubMed ID: 10579144
[TBL] [Abstract][Full Text] [Related]
14. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
[TBL] [Abstract][Full Text] [Related]
16. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
17. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
Główka FK; Caldwell J
Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration.
Mauleon D; Mis R; Ginesta J; Ortega E; Vilageliu J; Basi N; Carganico G
Chirality; 1994; 6(7):537-42. PubMed ID: 7986668
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
